Heron Therapeutics (HRTX) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Heron Therapeutics (HRTX) reported $36.02 million in revenue for the quarter ended June 2024, representing a year-over-year increase of 13.4%. EPS of -$0.06 for the same period compares to -$0.35 a year ago. The reported revenue compares to the Zacks Consensus Estimate of $35.35 million, representing a surprise of +1.91%. The company delivered an EPS surprise of -50.00%, with the consensus EPS estimate being -$0.04. While investors closely watch year-over-year changes in headline numbers -- revenue and earn ...